Therapeutic Gene Silencing Delivered by a Chemically Modified Small Interfering RNA against Mutant SOD1 Slows Amyotrophic Lateral Sclerosis Progression
Open Access
- 1 June 2008
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 283 (23) , 15845-15852
- https://doi.org/10.1074/jbc.m800834200
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- On future’s doorstep: RNA interference and the pharmacopeia of tomorrowJournal of Clinical Investigation, 2007
- Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficitsProceedings of the National Academy of Sciences, 2007
- Effective RNAi-mediated gene silencing without interruption of the endogenous microRNA pathwayNature, 2007
- Technology Insight: therapeutic RNA interference—how far from the neurology clinic?Nature Clinical Practice Neurology, 2007
- Design and Creation of New Nanomaterials for Therapeutic RNAiACS Chemical Biology, 2007
- Illuminating the silence: understanding the structure and function of small RNAsNature Reviews Molecular Cell Biology, 2007
- Antisense oligonucleotide therapy for neurodegenerative diseaseJournal of Clinical Investigation, 2006
- Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathwaysNature, 2006
- Position-specific chemical modification of siRNAs reduces “off-target” transcript silencingRNA, 2006
- Synthesis of Uridine Phosphoramidite Analogs: Reagents for Site-Specific Incorporation of Photoreactive Sites into RNA SequencesBioconjugate Chemistry, 1994